Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 95 | BSPED2023 | Next issue

50th Annual Meeting of the British Society for Paediatric Endocrinology and Diabetes

Manchester, UK
08 Nov 2023 - 10 Nov 2023

Card image cap
The 50th Annual BSPED Meeting will take place at the Midland Hotel, Manchester from 8-10 November 2023.

Poster Presentations

Late effects of cancer treatment

ea0095p51 | Late effects of cancer treatment | BSPED2023

Glucagon-like peptide-1 (GLP-1) receptor agonists as a new treatment option for hypothalamic obesity in the paediatric population: Preliminary data from a tertiary paediatric endocrine centre

Hawton Katherine , Chatterjee Sumana , Giri Dinesh , Crowne Elizabeth

Background: Hypothalamic obesity (HO) is defined as rapid weight gain, hyperphagia and lack of satiety due to physical hypothalamic destruction. HO does not usually respond to lifestyle modification and no pharmacotherapies are specifically approved for treating HO. Efficacy of glucagon-like peptide-1 (GLP-1) agonists, which suppress appetite via hypothalamic satiety centres, is uncertain in HO.Case series: We commenced ...

ea0095p53 | Late effects of cancer treatment | BSPED2023

Precocious puberty and other endocrine disorders during mitotane treatment for pediatric adrenocortical carcinoma – cases series

Moszczyńska Elżbieta , Baszyńska-Wilk Marta , Tutka Aleksandra , Bogusz-Wojcik Agnieszka , Dasiewicz Patrycja , Walewska-Wolf Małgorzata , Stepaniuk Maria , Grajkowska Wiesława , Majak Dorota , Gryniewicz-Kwiatkowska Olga

Introduction: Adrenocortical carcinoma (ACC) is a rare and aggressive tumor. Mitotane has been the mainstay adjuvant therapy of ACC. The study aimed to describe patients diagnosed with precocious puberty (PP) and other endocrinological disorders during mitotane treatment.Material and methods: This retrospective study enrolled four children with ACC treated with mitotane complicated by PP. The patients were diagnosed at C...